2511 — HighTide Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- HK$2.05bn
- HK$1.68bn
Annual balance sheet for HighTide Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 765 | 840 | 736 | 491 | 503 |
| Net Total Receivables | 3.64 | 2.34 | 16.3 | 10.9 | 0.547 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 775 | 851 | 779 | 513 | 532 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.45 | 4.81 | 15 | 23.9 | 17.6 |
| Other Long Term Assets | |||||
| Total Assets | 779 | 856 | 795 | 560 | 551 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 28.5 | 1,320 | 79.8 | 110 | 98.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,051 | 1,326 | 92.3 | 136 | 244 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -272 | -471 | 703 | 424 | 307 |
| Total Liabilities & Shareholders' Equity | 779 | 856 | 795 | 560 | 551 |
| Total Common Shares Outstanding |